Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 80
Filtrar
1.
Ann Cardiol Angeiol (Paris) ; 62(5): 308-15, 2013 Nov.
Artigo em Francês | MEDLINE | ID: mdl-24060465

RESUMO

INTRODUCTION: Cardiovascular causes are the first causes of death in elderly patients. Nevertheless, elderly patients are underrepresented in randomized studies of acute coronary syndromes although treatment of ACS for elderly patients has specificities that need special attention. METHODS AND RESULTS: To discuss these specificities, we realized a retrospective study involving patients aged more than 75years old and admitted for ACS in the cardiology department of Aix-en-Provence General Hospital in the first six months of 2010 (Group A) and 2012 (Group B) which we compared. Initial presentation was chest pain in only 78.6% of Group A versus 81.6% in Group B (NS), renal insufficiency was found in 41.4% of the patients of Group A versus 50.5% of the patients in Group B (NS), anaemia was found in 34.3% of Group A patients versus 40.2% of Group B (NS), invasive strategy is less systematic with 74.2% of Group A patients having a revascularization versus 73.6% of Group B (NS), Drug Eluting Stents were less frequently used with 14.3% of Group A patients versus 14.7% of Group B (NS), radial access was used for angioplasty in 61.2% of Group A patients versus 80.2% of Group B (P=0.02), unfractioned heparin was used in 74.3% of the cases in Group A versus 68% in Group B (NS). DISCUSSION AND CONCLUSION: Acute coronary syndrome of the elderly patients has numerous specificities, first there are frequent unusual presentation making diagnosis more difficult, second they have frequent co morbidities making them frail patients with higher risk of hemorrhagic complications and lesser tendency to invasive evidence based treatment. In the absence of specific recommendations, their treatment should not differ from younger patients. This work allowed us also to evaluate our professional practices in order to improve them; we note a positive evolution with the significant raise in the use of radial access, invasive strategy though should be more systematic and use of low molecular weight heparin and Fondaparinux should be more frequent.


Assuntos
Síndrome Coronariana Aguda/mortalidade , Síndrome Coronariana Aguda/terapia , Angioplastia Coronária com Balão/estatística & dados numéricos , Stents Farmacológicos/estatística & dados numéricos , Idoso , Idoso de 80 Anos ou mais , Anemia/epidemiologia , Angioplastia Coronária com Balão/efeitos adversos , Angioplastia Coronária com Balão/métodos , Anticoagulantes/uso terapêutico , Transfusão de Sangue/estatística & dados numéricos , Dor no Peito/epidemiologia , Dor no Peito/etiologia , Trombose Coronária/epidemiologia , Stents Farmacológicos/efeitos adversos , Dispneia/epidemiologia , Dispneia/etiologia , Fadiga/epidemiologia , Fadiga/etiologia , Feminino , França/epidemiologia , Hemorragia/epidemiologia , Heparina/uso terapêutico , Hospitalização , Hospitais Gerais , Humanos , Masculino , Inibidores da Agregação Plaquetária/uso terapêutico , Artéria Radial , Insuficiência Renal/epidemiologia , Estudos Retrospectivos , Acidente Vascular Cerebral/epidemiologia
3.
Ann Cardiol Angeiol (Paris) ; 56(5): 183-7, 2007 Nov.
Artigo em Francês | MEDLINE | ID: mdl-17920558

RESUMO

Electrical storm is defined as repeated occurrence of severe ventricular arrhythmias requiring multiple cardioversions, two or more or three or more following different studies. The clinical aspect can sometimes be made of multiple, self aggravating, life threatening accesses. There are three main clinical circumstances of occurrence: in patients equipped with intracardiac defibrillators, during the acute phase of myocardial infarction and in Brugada syndrome. 10 to 15% of patients with cardiac defibrillators are subject to electrical storms in a period of two years. The causative arrhythmia is most often ventricular tachycardia than ventricular fibrillation, especially in secondary prevention and if the initial arrhythmias justifying the device was a ventricular tachycardia. Precipitaing factors are present in one third of cases, mainly acute heart failure, ionic disorders and arrhythmogenic drugs. Predictive factors are age, left ventricular ejection fraction<35% and renal insufficiency. Arrhythmia reduction is obtained by electrical shock in 50% of cases, antitachycardi stimulation in 30% and in 20% by association of the two. Treatment, after elimination of inappropriate shocks, is mainly based on beta-blockers and amiodarone, class I antiarrhythmics, lidocaïne or bretylium in some cases, and sedation pushed to general anesthesia in some cases. Radio-frequency ablation and even heart transplantation have been proposed in extreme cases. Quinidine has been proved efficient in cases of Brugada syndrome.


Assuntos
Arritmias Cardíacas/terapia , Cardioversão Elétrica , Ventrículos do Coração , Arritmias Cardíacas/epidemiologia , Humanos , Recidiva , Retratamento , Índice de Gravidade de Doença
5.
Ann Cardiol Angeiol (Paris) ; 55(6): 321-7, 2006 Nov.
Artigo em Francês | MEDLINE | ID: mdl-17191590

RESUMO

QT prolongation is essentially of pharmacologic origin. It is principally linked to a block of the outward potassium current Ikr, with as a consequence a prolongation of the repolarisation causing early after potentials and re-entry. The term "repolarisation reserve" expresses the variable risk of arrhythmia among individuals under the same drug blocking Ikr. This reserve can be altered under various pathologic or genetic conditions. A series of risk factors (bradycar-Torsades de pointes} were described in 1966 by Dessertenne. They are due to a perturbation of ventricular repolarisation causing QT prolongation on surface ECG. Acquired dia, electrolytic disorders, cardiac disease, neurologic disorders, nutrition troubles, female gender) can play a role as well as the metabolic processing of pharmacological agents by Cytochrome P450 and various inhibitors or inductors of this system which can influence the half life of drugs. The list of drugs involved is continuously increasing: antiarrhythmics, antihistamines, psychotropics, anti-infectious are the main categories involved. Risk prediction is difficult particularly for non cardiovascular drugs and a low risk incidence. An other risk is to exclude patients from the benefit of an efficient drug for a serious but not frequent risk, at last an industrial risk for the manufacturer when a drug is withdrawn lately when important quantities of money have already been invested for its development. The diagnosis of torsades is easy on standard ECG although QT measurement and its heart rate variation remain uneasy. The treatment of the arrhythmias is based on heart rate acceleration by Isoprenaline or intravenous pacing and on intravenous administration of magnesium.


Assuntos
Eletrocardiografia , Síndrome do QT Longo/diagnóstico , Síndrome do QT Longo/etiologia , Agonistas Adrenérgicos beta/uso terapêutico , Quimioterapia Combinada , Cardioversão Elétrica , Humanos , Isoproterenol/uso terapêutico , Síndrome do QT Longo/terapia , Magnésio/administração & dosagem , Magnésio/uso terapêutico , Fatores de Risco
6.
Ann Cardiol Angeiol (Paris) ; 55(4): 230-2, 2006 Aug.
Artigo em Francês | MEDLINE | ID: mdl-16922175

RESUMO

We report a case of aortocoronary bypass graft aneurysm revealed by exertional dyspnea and presenting as an anterior mediastinal mass at the unenhanced computed tomography scan. The diagnosis has been established using combined contrast-enhanced CT scan which specified the vascular nature of the mass and coronary angiography which connected it to the aorto-marginal branch saphenous vein graft. This case illustrates the frequently asymptomatic expression of aneurysm and the importance of combined imaging modalities for the diagnosis.


Assuntos
Aneurisma/diagnóstico , Aneurisma/etiologia , Ponte de Artéria Coronária , Complicações Pós-Operatórias , Veia Safena/transplante , Idoso , Idoso de 80 Anos ou mais , Aneurisma/complicações , Angiografia Coronária , Dispneia/etiologia , Humanos , Masculino , Tomografia Computadorizada por Raios X
10.
Ann Cardiol Angeiol (Paris) ; 52(6): 353-7, 2003 Dec.
Artigo em Francês | MEDLINE | ID: mdl-14752917

RESUMO

Cardiac echodoppler is an efficient tool to analyse cardiac mechanic loop. Diastolic and systolic desynchronisation criteria are analysed. It should allow a more efficient selection of patients who could take benefit of resynchronization therapy, but also to choose resynchronization system, to program optimal atrioventricular delay, interventricular delay and to evaluate resynchronization efficiency. However, this tool should be evaluated in large studies in order to compare it to electrocardiogram.


Assuntos
Estimulação Cardíaca Artificial , Ecocardiografia Doppler , Insuficiência Cardíaca/terapia , Seleção de Pacientes , Diástole/fisiologia , Insuficiência Cardíaca/fisiopatologia , Humanos , Sístole/fisiologia
11.
Ann Cardiol Angeiol (Paris) ; 51(5): 289-95, 2002 Nov.
Artigo em Francês | MEDLINE | ID: mdl-12515106

RESUMO

Cardiac pacing has been proposed for patients with advanced heart failure refractory to optimal drug treatment and having conduction disorders to resynchronize mechanical activity of the heart. Activation asynchronism as caused by bundle branch block results in alteration of systolic function and arrhythmias. A too short or too long atrio-ventricular delay can also affect diastolic ventricular filling. Early clinical studies showed a benefit of very long atrioventricular delays shortening, not confirmed by further studies. Direct stimulation of the left ventricle was beneficial in acute hemodynamic studies. Three controlled clinical studies now completed, PATH-CHF, MYSTIC and MIRACLE have showed a functional benefit. Other studies (COMPANION, CARE-HF) are currently in process to evaluate the effect on survival and the interest to associate an automatic defibrillator. Technical aspects are also under investigation: optimal lead placement in the coronary venous system, types of leads, special pacing devices. This paper reports the experience of the first 50 patients treated with multisite pacing in Aix-en-Provence general hospital, 33 men and 17 women, 71 years of mean age, on NYHA class III or IV, and showing QRS width above 120 ms. During the follow-up (mean duration 16 months) 15 deaths (30%) happened. The benefit on NYHA class was 1.34; rehospitalization rate was low. Coronary sinus access was successful in 100% of cases. Sixteen per cent had a reintervention for lead displacement or threshold elevation. Left atrioventricular crosstalk, observed in six patients, supports the use of devices with three independent channels. Echocardiography is of interest for responders identification, optimal device programming and follow-up.


Assuntos
Bloqueio de Ramo/terapia , Estimulação Cardíaca Artificial , Insuficiência Cardíaca/terapia , Idoso , Idoso de 80 Anos ou mais , Bloqueio de Ramo/complicações , Estimulação Cardíaca Artificial/métodos , Desfibriladores Implantáveis , Feminino , Seguimentos , Insuficiência Cardíaca/complicações , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Resultado do Tratamento
12.
Arch Mal Coeur Vaiss ; 91 Spec No 1: 61-9, 1998 Mar.
Artigo em Francês | MEDLINE | ID: mdl-9749286

RESUMO

Some electrocardiographic appearances in cardiac pacing may suggest pacemaker dysfunction but in fact the unit may be functioning normally or have a minor fault which is easy to correct by reprogramming. A pacing rate different to that programmed may be due to the rate-response hysteresis or rate smoothing functions. Irregular pacing is often due to phenomena of inappropriate sensing. A pacemaker in the bipolar AAI mode may seem to have no output if the spike is not visible: function in AAI mode should not be interpreted as pacing catheter displacement. The practician may wrongly interpret faulty ventricular sensing in patients with AAI pacemakers and atrial fibrillation when irregular pacing is observed or when ventricular extrasystoles do not inhibit the pacemaker. In dual chamber pacing, the blanking period may result in inadequate ventricular stimulation. The phenomenon of crossed detection or cross-talk is a cause of inappropriate inhibition. Applications of the magnet blocks the sensing function: the magnet pacemaker rate is an indicator of pacemaker end of life. In fact, the magnet induces different behaviours depending on the model of pacemaker which makes it essential to know the special characteristics of each pacemaker. The application of the magnet may trigger arrhythmias or no output of pacemakers at the end of life. The A-V interval may vary with respect to its response to the heart rate, when there is a hysteresis function of the A-V interval, sensing in the "safety" gap or when anti-atrial trachycardia algorithms are activated. The acceleration of a dual-chamber pacemaker may be related to electronic reentrant tachycardia or to an atrial tachycardia: a fault or delayed activation of various anti-arrhythmic algorithms may also cause difficulties in the interpretation of the electrocardiogram.


Assuntos
Arritmias Cardíacas/terapia , Estimulação Cardíaca Artificial , Eletrocardiografia , Arritmias Cardíacas/fisiopatologia , Eletrofisiologia , Humanos
13.
Arch Mal Coeur Vaiss ; 90(11): 1545-8, 1997 Nov.
Artigo em Francês | MEDLINE | ID: mdl-9539830

RESUMO

A seventeen year old girl with anorexia nervosa (32 kg; 165 cm) was admitted as an emergency after syncope with severe bradycardia resistant to atropine monitored over a one week period. Autonomic blockade confirmed the intrinsic character of the sinus node dysfunction with chronotropic incompetence on exercise. Secondarily, a Mobitz I second degree AVB was observed. A DDDR pacemaker was implanted with an excellent functional result. With a one year follow-up, the bradycardia persists but body weight has increased. The authors discuss the physiopathology of this case: in the literature, the classical bradycardia of anorexia nervosa is sensitive to vagolytic drugs and only exceptionally as intense as in this patient. Sinus node dysfunction is very rare in the young in the absence of congenital heart disease. It is possible that the bradycardia had become chronic in this case.


Assuntos
Anorexia Nervosa/complicações , Bradicardia/etiologia , Bradicardia/terapia , Marca-Passo Artificial , Adolescente , Anorexia Nervosa/fisiopatologia , Diagnóstico Diferencial , Feminino , Frequência Cardíaca , Humanos , Nó Sinoatrial/fisiopatologia , Síncope/etiologia , Resultado do Tratamento
14.
Pacing Clin Electrophysiol ; 18(9 Pt 1): 1636-43, 1995 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-7491307

RESUMO

Unexplained syncope is the main indication for the implantation of a diagnostic pacemaker. Studies on those implanted have shown that in patients with unexplained syncope, the diagnosis of paroxysmal bradycardia was feasible and reliable. The present study was designed to evaluate a new bradycardia diagnosis algorithm, loaded in a dual chamber pacemaker, in 24 patients considered as candidates for diagnostic pacemakers. During a mean follow-up of 153 days, at least one bradycardia episode was recorded in 13 patients. The mean number of detected bradycardias was 6 and the median was 3. The mean delay between the algorithm activation and the first bradycardia episode was 67 days. The mechanism of bradycardia was atrioventricular block in 6 patients, sinus node dysfunction in 6 patients, and consecutive blocked atrial premature beats in 1 patient, as indicated by the event markers. In 11 patients bradycardia was recorded during the daytime only or day and night. In two patients the episodes were recorded only at night. Overall, the algorithm was well-tolerated; however, some mild symptoms were observed due to the method of bradycardia determination, allowing bradycardia. Three patients were symptomatic as a direct result of the algorithm operation, and four patients had symptoms related to the single chamber operation of the pacemaker while functioning in the diagnosis mode (VDI). These symptoms were relieved with DDD pacing.


Assuntos
Bradicardia/diagnóstico , Marca-Passo Artificial , Idoso , Algoritmos , Arritmia Sinusal/diagnóstico , Complexos Atriais Prematuros/diagnóstico , Bradicardia/terapia , Estimulação Cardíaca Artificial , Eletrocardiografia , Desenho de Equipamento , Estudos de Viabilidade , Feminino , Seguimentos , Bloqueio Cardíaco/diagnóstico , Humanos , Masculino , Pessoa de Meia-Idade , Reprodutibilidade dos Testes , Síndrome do Nó Sinusal/diagnóstico , Síncope/diagnóstico
15.
Arch Mal Coeur Vaiss ; 88(4): 451-7, 1995 Apr.
Artigo em Francês | MEDLINE | ID: mdl-7646262

RESUMO

Pacemakers with diagnostic functions have been implanted for several years. The main clinical indication for these devices is unexplained syncope. Some reports of the use of diagnostic pacemakers have shown that in patients with unexplained syncope, paroxysmal bradycardia was a common finding after implantation. Until recently, diagnostic functions were only available in VVI pacemakers, which explains the limitations of this type of function in determining the mechanism of the bradycardia. The aim of this study was to assess a new dual-chamber diagnostic pacemaker functioning in the VDI mode. Twenty-three patients were implanted with this type of unit and followed up for an average of 153 days. The number of episodes of bradycardia detected was 6 +/- 10 (median: 3). The interval between the installation of the algorithm and the date of the first episode of bradycardia was 67 +/- 86 days (range: 12-306 days). The mechanisms of the bradycardia were atrioventricular block (6 patients), sinus node dysfunction (6 patients) and blocked atrial bigeminy in 1 patient. These conclusions were drawn from analysis of chains of markers. Bradycardia was recorded during the day or during the day and night in 21 patients; bradycardia was exclusively nocturnal in only 2 patients. The tolerance of the algorithm was good on the whole but 3 patients reported minor symptoms related to the relative bradycardia inherent with this type of algorithm. Four other patients had a VDI pacemaker syndrome which was completely corrected by reprogramming the pacemaker to the standard DDD mode. These new devices represent a technical advance in the field of diagnostic pacemakers.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Bradicardia/diagnóstico , Marca-Passo Artificial , Idoso , Algoritmos , Bradicardia/etiologia , Bradicardia/fisiopatologia , Feminino , Bloqueio Cardíaco/complicações , Bloqueio Cardíaco/fisiopatologia , Cardiopatias/complicações , Cardiopatias/fisiopatologia , Humanos , Masculino , Pessoa de Meia-Idade , Síncope/etiologia , Síncope/fisiopatologia , Fatores de Tempo
17.
Arch Mal Coeur Vaiss ; 85(12): 1831-5, 1992 Dec.
Artigo em Francês | MEDLINE | ID: mdl-1306625

RESUMO

A national enquiry carried out in 1990 in the departments of cardiology of general and private non-profit making hospitals established the status of these departments and the evolution of their personnel and equipment since their creation. The enquiry involved two thirds of the cardiology departments of the general hospitals (119/180) and showed that most (66%) were established between 1974 and 1988. Implanted in fairly important cities with catchment areas of 100,000 to 400,000 people, they have an average of 32 beds (range 11 to 100) and 7.25 coronary care beds (range 4 to 19); 347 doctors work full (211) or part time (136) in these departments. These two types of work are allowed in the majority of these units (64/119). Specialist certified cardiologists practice in 62 departments (56%). The usual technical equipment is available in 80% of the units (Doppler echocardiography, exercise stress testing, Holter monitoring, right heart catheterisation). Permanent pacing is performed in 65% of these hospitals, more so in the provinces than in the Paris region. Coronary angiography is only available in 21%, radioisotopic investigations in 15% and coronary angioplasty in 12% of these centres. A prospective study performed in 1990 concerning 110 hospitals recruited 1,030 myocardial infarctions, which enabled the total number of infarcts hospitalised in the coronary care units of the general hospitals to be estimated at about 21,000 (60% of French myocardial infarctions).


Assuntos
Cardiologia/organização & administração , Inquéritos Epidemiológicos , Angioplastia/estatística & dados numéricos , Cardiologia/instrumentação , Angiografia Coronária/estatística & dados numéricos , Unidades de Cuidados Coronarianos , França , Hospitais Gerais , Humanos , Tempo de Internação , Recursos Humanos
18.
Ann Cardiol Angeiol (Paris) ; 41(8): 449-53, 1992 Oct.
Artigo em Francês | MEDLINE | ID: mdl-1298185

RESUMO

Disopyramide is a Vaughan-Williams class Ia antiarrhythmic, which is distinguished by its anticholinergic activity, which is due to its active metabolite: mono-N-alkyl disopyramide. In cells with a rapid response, such as those in the His-Purkinje tissue, it depresses conduction. In slow-responding cells (sinus node and Tawara's node) direct depression of conduction and automatism, and anticholinergic stimulation have opposing effects. In terms of clinical electrophysiology, this is a Touboul class IIa compound: and action mainly on the His-Purkinje system involving extension of the conduction time and of the refractory time. Nodal conduction is improved according to measurement of the alternate Wenckebach; according to studies of the denervated heart in transplanted patients, there is a depressant effect on automatism and conduction at all levels, but the vagolytic effect corrects this activity at Tawara's node. Clinical trials have demonstrated the absence of any deterioration, and in some cases and actual improvement of nodal conduction disorders in response to disopyramide and good safety in the presence of non-major intraventricular conduction problems (such as bundle branch block). In practice, these properties mean that moderate nodal conductive disorders and simple bundle branch block do not constitute an obstacle to the use of disopyramide. In junctional tachycardia, it is particularly indicated for use in tachycardia involving an accessory pathway, but is also effective in intranodal tachycardia due to its twofold action.


Assuntos
Arritmias Cardíacas/tratamento farmacológico , Disopiramida/farmacologia , Sistema de Condução Cardíaco/efeitos dos fármacos , Eletrofisiologia , Humanos
19.
Ann Cardiol Angeiol (Paris) ; 39(4): 233-6, 1990 Apr.
Artigo em Francês | MEDLINE | ID: mdl-2369060

RESUMO

The topographic diagnoses of Kent's bundles obtained from vectorcardiograms with maximum preexcitation in 33 patients (dynamic VCH) were compared with those obtained using Franck's new algorithm. Only three cases disagreed, and the three anteroseptal topographies were identified a posteriori. This simple method therefore shows very satisfactory sensitivity (82%) and provides worthwhile orientation for later investigations.


Assuntos
Sistema de Condução Cardíaco/fisiopatologia , Vetorcardiografia , Síndrome de Wolff-Parkinson-White/fisiopatologia , Adulto , Algoritmos , Eletrocardiografia , Feminino , Humanos , Masculino
20.
Pediatrie ; 44(5): 375-7, 1989.
Artigo em Francês | MEDLINE | ID: mdl-2812963

RESUMO

Two monozygotic twin sisters presented a familial nephropathy, discovered at 5 years of age. The clinical course was quite different for each patient: end-stage renal failure occurred at 5.5 years of age for one and at 14 years for the other. This difference raises the hypothesis of the role of environmental factors on the clinical expression of an inherited disease.


Assuntos
Doenças em Gêmeos , Falência Renal Crônica/fisiopatologia , Gêmeos Monozigóticos , Gêmeos , Adolescente , Fatores Etários , Criança , Feminino , Humanos , Transplante de Rim
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA